SMY: (2R)-3-(1H-indol-3-yl)-1-{4-[(5S)-5-methyl-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]piperazin-1-yl}-1-oxopropan-2-amine
SMY is a Ligand Of Interest in 3OW4 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3OW4_SMY_A_1 | 76% | 21% | 0.094 | 0.932 | 1.08 | 2.07 | 1 | 13 | 8 | 0 | 100% | 1 |
| 3OW4_SMY_B_2 | 64% | 20% | 0.111 | 0.91 | 1.03 | 2.22 | 1 | 18 | 6 | 0 | 100% | 1 |
| 3OW3_SMY_A_401 | 35% | 7% | 0.161 | 0.851 | 1.43 | 3.15 | 9 | 20 | 39 | 0 | 100% | 1 |
